Stereotactic Ablative Radiotherapy With Nivolumab for Early-Stage Operable Non-Small Cell Lung Cancer

Condition:   Non-small Cell Lung Cancer Stage I Intervention:   Combination Product: nivolumab Sponsor:   Hospital Israelita Albert Einstein Recruiting

Source: ClinicalTrials.gov - February 17, 2020 Category: Research Source Type: clinical trials